• Neurosense Therapeutics Ltd is trading 5.6% up at $0.85 in pre-market, extending a sharp rebound from recent lows.
  • The company is expected to announce its Q1'26 earnings results today, June 22, 2026, which appears to be driving the pre-market momentum.